CD123-CD16-NK Cells Immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD123-CD16-NK Cells Immunotherapy, covering 2025-02-25 to 2025-02-25. Get the full timeline:
Most recent: Clinical Trial Update: CD123-CD16-NK Cells Immunotherapy for AML [Phase 1]